Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria Patients
Open Access
- 25 February 2022
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-6
Abstract
Background. Association between chronic spontaneous urticaria (CSU) and autoimmunity has been well documented. Autologous serum skin testing could support the autoimmune etiology of CSU, whereas it is difficult to interpret and could not be performed on antihistamine omitted patients. It was found that immunoglobulin G (IgG) autoantibodies (autoAbs) against high-affinity IgE receptor (FcεR1) were suggested as a potential trigger in the pathogenesis of CSU. Although many ELISA protocols have been developed to detect these autoAbs, they lacked validation or a reliable cut-off point. We, therefore, aimed to develop a validated ELISA with a reliable cut-off point to quantitate IgG anti-FcεR1α autoAbs for CSU. Methods. We developed an in-house ELISA to quantitate IgG anti-FcεR1α autoAbs. Sera from 233 CSU patients and 25 healthy people were used to test with ELISA. The cut-off point was obtained from the results subjected to analyze with receiver operating characteristic (ROC) analysis. ELISA was validated with 116 CSU patients and 150 healthy donors. Results. ELISA revealed that healthy people had a basal level of IgG anti-FcεR1α autoAbs, whereas their levels were significantly lower than autoAbs levels in CSU patients. ROC analysis of ELISA determined the cut-off point at 936.7ng/ml. Our ELISA was validated and provided excellent sensitivity and specificity at 98.28 and 92.67, respectively. Conclusion. Our ELISA could detect significant levels of IgG anti-FcεR1α autoAbs in CSU, supporting that these autoAbs were associated with CSU etiology. Our validated ELISA with the reliable cut-off point provided excellent accuracy at 95.11 (98.28 sensitivity and 92.67 specificity). Our ELISA could be an alternative test benefit for the patient who is unable to omit antihistamine treatment.Keywords
Funding Information
- Faculty of Medicine Siriraj Hospital, Mahidol University
This publication has 34 references indexed in Scilit:
- IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria?PLOS ONE, 2011
- Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin testJournal of the European Academy of Dermatology and Venereology, 2011
- Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2Clinical Immunology, 2009
- Evaluation of autologous serum skin test results in patients with chronic idiopathic urticaria, allergic/non-allergic asthma or rhinitis and healthy peopleClinical and Experimental Dermatology, 2008
- Basophil Phenotypes in Chronic Idiopathic Urticaria in Relation to Disease Activity and AutoantibodiesJournal of Investigative Dermatology, 2008
- Autologous Whole Blood Injections to Patients with Chronic Urticaria and a Positive Autologous Serum Skin Test: A Placebo-Controlled TrialDermatology, 2006
- In chronic idiopathic urticaria autoantibodies against FcɛRII/CD23 induce histamine release via eosinophil activationClinical & Experimental Allergy, 2005
- The autologous serum skin test in the follow‐up of patients with chronic urticariaAllergy, 2005
- Reactivity to autologous serum skintest and clinical features in chronic idiopathic urticariaClinical and Experimental Dermatology, 2002
- Src homology 2 domain–containing inositol 5' phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophilsJournal of Allergy and Clinical Immunology, 2001